LPS reduces HIV-1 replication in primary human macrophages partly through an endogenous production of type I interferons

Clinical Immunology

Volumn 127, Issue 2, 2008, Pages 198-205

  Simard, Sébastien ^a   Maurais, Émilie ^a   Gilbert, Caroline ^b   Tremblay, Michel J ^a  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

AIDS; HIV; Human; Lipopolysaccharide; Macrophages

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; LIPOPOLYSACCHARIDE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VACCINIA VIRUS; VIRUS INFECTION; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

EID: 41749123691     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.01.007     Document Type: Article

References (50)

1. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., Nguyen P.L., Khoruts A., Larson M., Haase A.T., and Douek D.C. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200 (2004) 749-759
2. Mehandru S., Poles M.A., Tenner-Racz K., Horowitz A., Hurley A., Hogan C., Boden D., Racz P., and Markowitz M. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200 (2004) 761-770
3. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., and Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12 (2006) 1365-1371
4. Taylor P.R., Martinez-Pomares L., Stacey M., Lin H.H., Brown G.D., and Gordon S. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23 (2005) 901-944
5. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168 (2002) 554-561
6. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
7. Haziot A., Chen S., Ferrero E., Low M.G., Silber R., and Goyert S.M. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141 (1988) 547-552
8. Schwartz D.A. The role of TLR4 in endotoxin responsiveness in humans. J. Endotoxin Res. 7 (2001) 389-393
9. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev., Immunol. 4 (2004) 499-511
10. Lee J., Mira-Arbibe L., and Ulevitch R.J. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J. Leukoc. Biol. 68 (2000) 909-915
11. Sakurai H., Nishi A., Sato N., Mizukami J., Miyoshi H., and Sugita T. TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways. Biochem. Biophys. Res. Commun. 297 (2002) 1277-1281
12. Covert M.W., Leung T.H., Gaston J.E., and Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309 (2005) 1854-1857
13. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., Hoshino K., and Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167 (2001) 5887-5894
14. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809 (table of contents)
15. Lu Y.C., Touzjian N., Stenzel M., Dorfman T., Sodroski J.G., and Haseltine W.A. The NF kappa B independent cis-acting sequences in HIV-1 LTR responsive to T-cell activation. J. Acquir. Immune Defic. Syndr. 4 (1991) 173-177
16. Bagasra O., Wright S.D., Seshamma T., Oakes J.W., and Pomerantz R.J. CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6285-6289
17. Equils O., Faure E., Thomas L., Bulut Y., Trushin S., and Arditi M. Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. J. Immunol. 166 (2001) 2342-2347
18. Equils O., Madak Z., Liu C., Michelsen K.S., Bulut Y., and Lu D. Rac1 and Toll-IL-1 receptor domain-containing adapter protein mediate Toll-like receptor 4 induction of HIV-long terminal repeat. J. Immunol. 172 (2004) 7642-7646
19. Lodie T.A., Reiner M., Coniglio S., Viglianti G., and Fenton M.J. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages. J. Immunol. 161 (1998) 268-276
20. Pomerantz R.J., Feinberg M.B., Trono D., and Baltimore D. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172 (1990) 253-261
21. Franchin G., Zybarth G., Dai W.W., Dubrovsky L., Reiling N., Schmidtmayerova H., Bukrinsky M., and Sherry B. Lipopolysaccharide inhibits HIV-1 infection of monocyte- derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J. Immunol. 164 (2000) 2592-2601
22. Equils O., Salehi K.K., Cornataeanu R., Lu D., Singh S., Whittaker K., and Baldwin G.C. Repeated lipopolysaccharide (LPS) exposure inhibits HIV replication in primary human macrophages. Microbes Infect. 8 (2006) 2469-2476
23. Bounou S., Leclerc J.E., and Tremblay M.J. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J. Virol. 76 (2002) 1004-1014
24. Ouellet M., Roy J., Barbeau B., Geleziunas R., and Tremblay M.J. NF-kappaB induction by bisperoxovanadium compounds requires CD45, p36(LAT), PKC, and IKK activity and exhibits kinetics of activation comparable to those of TCR/CD28 coengagement. Biochemistry 42 (2003) 8260-8271
25. Brown K., Park S., Kanno T., Franzoso G., and Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 2532-2536
26. Symons J.A., Alcami A., and Smith G.L. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81 (1995) 551-560
27. Alcami A., Symons J.A., and Smith G.L. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J. Virol. 74 (2000) 11230-11239
28. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., and Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (1995) 123-126
29. Wei X., Ghosh S.K., Taylor M.E., Johnson V.A., Emini E.A., Deutsch P., Lifson J.D., Bonhoeffer S., Nowak M.A., Hahn B.H., et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373 (1995) 117-122
30. Verani A., Gras G., and Pancino G. Macrophages and HIV-1: dangerous liaisons. Mol. Immunol. 42 (2005) 195-212
31. Gartner S., Markovits P., Markovitz D.M., Kaplan M.H., Gallo R.C., and Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233 (1986) 215-219
32. Koyanagi Y., O'Brien W.A., Zhao J.Q., Golde D.W., Gasson J.C., and Chen I.S. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241 (1988) 1673-1675
33. Crowe S., Zhu T., and Muller W.A. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J. Leukoc. Biol. 74 (2003) 635-641
34. Kedzierska K., and Crowe S.M. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr. Med. Chem. 9 (2002) 1893-1903
35. Gordon S.B., and Read R.C. Macrophage defences against respiratory tract infections. Br. Med. Bull. 61 (2002) 45-61
36. Jones G., and Power C. Regulation of neural cell survival by HIV-1 infection. Neurobiol. Dis. 21 (2006) 1-17
37. Persaud D., Pierson T., Ruff C., Finzi D., Chadwick K.R., Margolick J.B., Ruff A., Hutton N., Ray S., and Siliciano R.F. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children. J. Clin. Invest. 105 (2000) 995-1003
38. Poggi C., Profizi N., Djediouane A., Chollet L., Hittinger G., and Lafeuillade A. Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infection. AIDS 13 (1999) 1213-1220
39. McElrath M.J., Pruett J.E., and Cohn Z.A. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 675-679
40. Kedzierska K., Crowe S.M., Turville S., and Cunningham A.L. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev. Med. Virol. 13 (2003) 39-56
41. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13 (1995) 437-457
42. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
43. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 (2004) 257-263
44. Doyle S., Vaidya S., O'Connell R., Dadgostar H., Dempsey P., Wu T., Rao G., Sun R., Haberland M., Modlin R., and Cheng G. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17 (2002) 251-263
45. Tesmer V.M., Rajadhyaksha A., Babin J., and Bina M. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7298-7302
46. Henderson A.J., Connor R.I., and Calame K.L. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5 (1996) 91-101
47. Lee E.S., Sarma D., Zhou H., and Henderson A.J. CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells. Virology 299 (2002) 20-31
48. Honda Y., Rogers L., Nakata K., Zhao B.Y., Pine R., Nakai Y., Kurosu K., Rom W.N., and Weiden M. Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J. Exp. Med. 188 (1998) 1255-1265
49. Henderson A.J., and Calame K.L. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 8714-8719
50. Tanaka N., Hoshino Y., Gold J., Hoshino S., Martiniuk F., Kurata T., Pine R., Levy D., Rom W.N., and Weiden M. Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages. Am. J. Respir. Cell Mol. Biol. 33 (2005) 406-411